NCT03468855View on ClinicalTrials.gov

A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 19, 2018

Primary Completion Date

October 16, 2019

Study Completion Date

October 16, 2019

Conditions
Vitiligo
Interventions
DRUG

ATI-50002 topical solution

Topical Solution administered twice daily

Trial Locations (5)

24501

Aclaris Investigator Site, Lynchburg

75390

Aclaris Investigator Site, Dallas

90036

Aclaris Investigator Site, Los Angeles

92024

Aclaris Investigator Site, Encinitas

01655

Aclaris Investigator Site, Worcester

Sponsors
All Listed Sponsors
lead

Aclaris Therapeutics, Inc.

INDUSTRY